What are the export prospects of pharmaceutical intermediates?

Many people in the foreign trade of pharmaceutical intermediates know less, haven't seen such a word, some foreign trade small white pharmaceutical intermediates is medicine after more complex process of material production, can become a kind of material, basic chemicals processed by chemical synthesis, to form a pharmaceutical intermediates, and then further forming active pharmaceutical ingredients, drug trade in foreign trade transactions requirement is more strict, It belongs to one of the six categories of dangerous goods. How can we improve the delivery rate in the process of foreign trade? This article will take the export of pharmaceutical intermediates as an example to help foreign traders export pharmaceutical products smoothly.

First, to understand the development of foreign trade in China's pharmaceutical intermediates industry

According to the data, according to medical market all over the world are on the rise, compared to about $700 billion of earnings growth in 2010 to nearly $900 billion, health care products is a great demand for the world's foreign trade goods, the increase of global population, medical and health care technology unceasing enhancement, the Chinese medical technology leap progress, However, the overall level of medicine in the world is still relatively low, and only some developed countries have a relatively high level of medical treatment. Therefore, the demand for Chinese pharmaceutical intermediates is also soaring. In the selection of export products by foreign traders, medicine has become a rigid demand. From the point of the industrial chain, the current domestic listed companies is still in the industrial chain of low-end, both in professional medical services, the core of pharmaceutical intermediates is one of the most important power, in the coming years, the world's new medicines such as rheumatism, brain function to improve drug resistance, anti-hiv drugs, antidepressants and other medicines are in urgent need of development research, as a producer in China, The pharmaceutical export trade industry has a very bright prospect.

Second, the choice of appropriate export channels

Hong Kong, shenzhen customs logistics professional to undertake logistics is more suitable for export pharmaceutical intermediates, and because of the nature of the drug itself, cause most of the value is higher, exports do not meet like other export goods exports, so suit to export the goods by Courier, and Hong Kong have some place to allow normal dangerous goods go Courier, with such a special transportation channel, It eliminates the tedious process brought by the ordinary mode of transportation and improves the efficiency of foreign trade export. Shenzhen logistics professional pharmaceutical raw materials, can also transport pesticide raw materials and various kinds of liquid powder, at the same time provide air, sea, express way, the mode of transportation is diversiform, can to a certain extent, provide some convenience for foreign trade transportation, drug classes can be actively looking for foreign trade member like mode of transportation, to form their own export transport chain, for a rainy day.

Third, through the production characteristics of pharmaceutical intermediates to analyze the prospects

Mostly private enterprises engaged in pharmaceutical intermediates, the private enterprise management way is flexible, not don't also big investment scale, especially suitable for export all kinds of foreign-invested enterprises, the saturation is not very full, to want to be engaged in pharmaceutical intermediates the opportunity of foreign trade business of foreign trade salesman is very big, every year in China reached more than 2000 types required raw materials and intermediates, The demand reaches more than 2.5 million tons, such a rich variety of raw materials and basic supporting facilities, only a small part of the need to import, the low price of raw materials, to achieve a large number of foreign trade export demand. Secondly, the distribution of pharmaceutical production enterprises is relatively concentrated, which can provide foreign trade supply and export to areas with high tolerance and large demand. The updating speed of drug products is also relatively fast. As long as you can have the resources or supply of new technologies, pay attention to the development of medical undertakings, and negotiate with suppliers in advance about foreign trade cooperation, you can achieve greater profits in the foreign trade areas with large demand. Moreover, compared with API, the cost of pharmaceutical intermediates is relatively low. However, the production process of API and intermediates is very similar. Many enterprises take advantage of the advantages of API and intermediates, and produce their own raw materials to make pharmaceutical intermediates. Now the demand for phenylacetic acid, fluoropyridine intermediates and other drugs continues to increase. As a foreign trade staff, we should be good at learning foreign trade data through big data and selling points through data-oriented analysis, which will provide us with more profit space.